You have 9 free searches left this month | for more free features.

Hepatic Arterial Infusion (HAI)

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hepatocellular Carcinoma Trial in Wuhan (HAIC, Sintilimab, Bevacizumab Biosimilar IBI305)

Recruiting
  • Hepatocellular Carcinoma
  • Wuhan, Hubei, China
    Union Hospital affiliated to Tongji Medical College of Huazhong
Nov 8, 2022

Hepatic Metastases, Colon Cancer, Rectal Cancer Trial in United States (Bevacizumab HAI plus systemic chemo, HAI plus systemic

Active, not recruiting
  • Hepatic Metastases
  • +2 more
  • Bevacizumab HAI plus systemic chemotherapy
  • HAI plus systemic chemotherapy
  • Basking Ridge, New Jersey
  • +4 more
Apr 26, 2022

Colorectal Cancer, Cholangiocarcinoma Trial in United States (Medtronic pump and Codman catheter, Floxuridine (FUDR),

Active, not recruiting
  • Colorectal Cancer
  • Cholangiocarcinoma
  • Medtronic pump and Codman catheter
  • +6 more
  • Basking Ridge, New Jersey
  • +6 more
Oct 3, 2022

Metastatic Colorectal Carcinoma, Metastatic Malignant Tumor in the Liver, Stage IV Colorectal Cancer AJCC v8 Trial (biological,

Not yet recruiting
  • Metastatic Colorectal Carcinoma
  • +3 more
  • Bevacizumab
  • +11 more
  • (no location specified)
May 9, 2023

Uveal Melanoma, Metastatic Cutaneous Melanoma Trial (Autologous Tumor Infiltrating Lymphocytes, Melphalan, Interleukin-2)

Not yet recruiting
  • Uveal Melanoma
  • Metastatic Cutaneous Melanoma
  • Autologous Tumor Infiltrating Lymphocytes
  • +2 more
  • (no location specified)
Jun 5, 2023

Hepatocellular Carcinoma Trial in Guangzhou (Raltitrexed, oxaliplatin (SALOX) treatment, Oxaliplatin, fluorouracil/leucovorin

Recruiting
  • Hepatocellular Carcinoma
  • Raltitrexed, oxaliplatin (SALOX) treatment
  • Oxaliplatin, fluorouracil/leucovorin (FOLFOX) treatment
  • Guangzhou, Guangdong, China
    Department of Minimally Invasive and Interventional Radiology, L
May 17, 2022

Colorectal Cancer, Cholangiocarcinoma Trial in Seattle (Medtronic pump and Codman catheter, Floxuridine (FUDR), Gemcitabine)

Recruiting
  • Colorectal Cancer
  • Cholangiocarcinoma
  • Medtronic pump and Codman catheter
  • +6 more
  • Seattle, Washington
    Virginia mason medical Center
Dec 17, 2020

Cholangiocarcinoma, Liver Tumors Trial in Saint Louis (Floxuridine, Dexamethasone, Gemcitabine)

Terminated
  • Cholangiocarcinoma
  • Liver Neoplasms
  • Saint Louis, Missouri
    Washington University School of Medicine
Aug 8, 2022

Liver and Intrahepatic Bile Duct Carcinoma, Stage III Intrahepatic Cholangiocarcinoma AJCC v8, Stage IIIA Intrahepatic

Recruiting
  • Liver and Intrahepatic Bile Duct Carcinoma
  • +5 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Oct 11, 2022

Recurrent Liver Cancer After Liver Transplantation Trial (Hepatic arterial infusion chemo + Atezolizumab and bevacizumab)

Not yet recruiting
  • Recurrent Liver Cancer After Liver Transplantation
  • Hepatic arterial infusion chemotherapy + Atezolizumab and bevacizumab
  • (no location specified)
Apr 17, 2023

Colorectal Cancer Metastatic Trial in Guangzhou (Dexamethasone, Anisodamine, Oxaliplatin)

Recruiting
  • Colorectal Cancer Metastatic
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Feb 3, 2023

HepaSphere Transarterial Chemoembolization Combined With Hepatic

Not yet recruiting
  • Colorectal Liver Metastases (CRCLM)
  • DEB-TACE plus HAIC
  • Beijing, Beijing, China
    Beijing Cancer Hospital
May 25, 2023

HepaSphere Drug-eluting Bead Transarterial Chemoembolization

Recruiting
  • Advanced Hepatocellular Carcinoma (HCC)
  • DEB-TACE plus HAIC or HAIC alone
  • Beijing, Beijing, China
    Beijing Cancer Hospital
May 19, 2023

Metastatic Colon Cancer, Liver Cancer, Intrahepatic Cholangiocarcinoma Trial (Medtronic Synchromed II pump)

Withdrawn
  • Metastatic Colon Cancer
  • +2 more
  • Medtronic Synchromed II pump
  • (no location specified)
Jul 13, 2021

Hepatocellular Carcinoma Trial in Tianjin (HAIC, Sintilimab, Bevacizumab Biosimilar)

Recruiting
  • Hepatocellular Carcinoma
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute & Hospital
Jan 16, 2022

Metastatic Uveal Melanoma, Metastatic Cutaneous Melanoma Trial (Autologous Tumor Infiltrating Lymphocytes, Melphalan,

Not yet recruiting
  • Metastatic Uveal Melanoma
  • Metastatic Cutaneous Melanoma
  • Autologous Tumor Infiltrating Lymphocytes
  • +2 more
  • (no location specified)
Oct 14, 2022

Colorectal Cancer, Metastatic Cancer Trial in United States (dexamethasone, floxuridine, fluorouracil)

Active, not recruiting
  • Colorectal Cancer
  • Metastatic Cancer
  • Basking Ridge, New Jersey
  • +4 more
Feb 4, 2022

Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma Trial in Houston (SD-101, Pembrolizumab, Nivolumab)

Recruiting
  • Hepatocellular Carcinoma
  • Intrahepatic Cholangiocarcinoma
  • New York, New York
  • +3 more
Oct 19, 2022

Metastatic Colorectal Cancer Trial in United States (panitumumab, Randomization to No Panitumumab)

Active, not recruiting
  • Metastatic Colorectal Cancer
  • Basking Ridge, New Jersey
  • +7 more
Apr 1, 2022

Thrombocytopenia, Hepatocellular Carcinoma Trial in Guangzhou (Avatrombopag)

Not yet recruiting
  • Thrombocytopenia
  • Hepatocellular Carcinoma
  • Guangzhou, Guangdong, China
    The Second Affiliated Hospital of Guangzhou Medical University
Aug 17, 2023

Hepatocellular Carcinoma Trial in Guangzhou (Atezolizumab, Bevacizumab, HAIC with FOLFOX)

Recruiting
  • Hepatocellular Carcinoma
  • Guangzhou, Guangdong, China
    Cancer Center Sun Yat-sen University
May 24, 2023

Advanced Colorectal Carcinoma, Liver Metastasis Colon Cancer Trial in Beijing (Fruquintinib, Hepatic Arterial Infusion

Recruiting
  • Advanced Colorectal Carcinoma
  • Liver Metastasis Colon Cancer
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Jun 1, 2022

Hepatocellular Carcinoma Trial in Guangzhou (HAIC, Zoledronic acid)

Recruiting
  • Hepatocellular Carcinoma
  • HAIC
  • Zoledronic acid
  • Guangzhou, Guangdong, China
    Cancer Center Sun Yat-sen University
May 10, 2023

Hepatocellular Carcinoma Trial (HAIC(FOLFOX), Oxaliplatin, Leucovorin)

Not yet recruiting
  • Hepatocellular Carcinoma
  • HAIC(FOLFOX)
  • +5 more
  • (no location specified)
Aug 16, 2022

Colorectal Liver Metastases Trial in Beijing (Tislelizumab, Regorafenib, HAIC)

Recruiting
  • Colorectal Liver Metastases
  • Beijing, Beijing, China
  • +1 more
May 25, 2023